1181182

Aerie Pharmaceuticals, Inc. — FEI 3012904411

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 28, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Irvine, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)